Hi, All,

How are how people are handling "e-credits" for COVID-19-related cancelled flights paid by sponsored funds?

The COGR FAQ on COVID-19 from 3/20/2020, questions #1 and #2, were very helpful in referencing 2CFR200 guidelines about this. I am sharing with administration the information about a) charging cancellation fees to sponsored funds for grant-related travel; b) documenting denied requests for refunds; c) making sure that credits are applied to the sponsored fund.

But, since airlines typically credit the individual with "e-credit," how is your institution tracking and planning use of the "e-credits" originally paid by the sponsored fund?

Patience Graybill, M.A., CRA
Manager, Research Development & Administration
Project Manager, Center for Engineering MechanoBiology (CEMB)
McKelvey School of Engineering
Washington University in St. Louis
ph. 314-935-8618 | f: 314.935.6949
xxxxxx@wustl.edu
One Brookings Drive |  Campus Box 1138 |  St. Louis, MO 63130-4899

-----Original Message-----
From: Research Administration List <xxxxxx@LISTS.HEALTHRESEARCH.ORG> On Behalf Of Larry Waxler
Sent: Tuesday, March 10, 2020 1:40 PM
To: xxxxxx@LISTS.HEALTHRESEARCH.ORG
Subject: Re: [RESADM-L] Travel reimbursement on federal grants

Cancellation fees are generally considered to be an allowable expense provided there is a legitimate reason e.g. a canceled conference or the medical emergency of the traveler. Not sure how the Feds would view a broad-based cancellation initiated by an institution in this case. Let's hope the Feds provide some timely guidance.

Larry

On 3/10/2020 1:13 PM, Johnson, Charlotte wrote:
> Has anyone developed a plan for reimbursing investigators and staff
> for cancelled meetings and travel?  Or, is everyone waiting to see an
> announcement from the feds?  My first thought is that these meetings
> and travel were not cancelled because of anything that we did so costs
> already incurred should be reimbursable.   Thoughts?
>
> Thanks, Charlotte
>
> *Charlotte A. Johnson *
>
> *Director, Office of Sponsored Programs*
>
> *Harvard Pilgrim Health Care, Inc*.**
>
> 401 Park Drive, Suite 401 EAST
>
> Boston, MA 02215
>
> 617-867-4929
>
> xxxxxx@HarvardPilgrim.org
> <mailto:xxxxxx@HarvardPilgrim.org>
>
> The information contained in this email message and any attachments
> may be privileged and/or confidential. It is for intended addressee(s) only.
> If you are not the intended recipient, you are hereby notified that
> any review, disclosure, reproduction, distribution or other use of
> this communication is strictly prohibited. If you received this email
> in error, please notify the sender by reply and delete the message
> without saving, copying or disclosing it. The information contained in
> this email message and any attachments may be privileged and/or confidential.
> It is for intended addressee(s) only. If you are not the intended
> recipient, you are hereby notified that any review, disclosure,
> reproduction, distribution or other use of this communication is
> strictly prohibited. If you received this email in error, please
> notify the sender by reply and delete the message without saving,
> copying or disclosing it.
> ----------------------------------------------------------------------
> --
>
> To unsubscribe from the RESADM-L list, click the following link:
> http://lists.healthresearch.org/scripts/wa-HLTHRES.exe?SUBED1=RESADM-L
> &A=1
>

############################

To unsubscribe from the RESADM-L list:
write to: mailto:xxxxxx@LISTS.HEALTHRESEARCH.ORG
or click the following link:
http://lists.healthresearch.org/scripts/wa-HLTHRES.exe?SUBED1=RESADM-L&A=1

############################

To unsubscribe from the RESADM-L list:
write to: mailto:xxxxxx@LISTS.HEALTHRESEARCH.ORG
or click the following link:
http://lists.healthresearch.org/scripts/wa-HLTHRES.exe?SUBED1=RESADM-L&A=1